{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:09:56Z","timestamp":1733875796584,"version":"3.30.1"},"reference-count":29,"publisher":"CAIRN","issue":"HS2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,7]]},"abstract":"<jats:p>Introduction : Les pratiques relatives \u00e0 l\u2019observance des hormonoth\u00e9rapies substitutives chez les personnes trans sont peu \u00e9tudi\u00e9es. Pour une grande partie de ces personnes, l\u2019hormonoth\u00e9rapie est administr\u00e9e par voie parent\u00e9rale. Or l\u2019indisponibilit\u00e9 de certains traitements en France, associ\u00e9e \u00e0 une prise en charge institutionnelle d\u00e9faillante, \u00e9loigne les injecteur\u00b7rice\u00b7s du syst\u00e8me de soin et favorise des pratiques d\u2019injection potentiellement \u00e0 risques. Suite \u00e0 une augmentation notable du nombre de personnes trans dans sa file active, l\u2019association Safe, coordinatrice du dispositif de r\u00e9duction des risques \u00e0 distance en France, a men\u00e9 une \u00e9tude descriptive transversale de d\u00e9cembre 2020 \u00e0 f\u00e9vrier 2021 \u00e0 l\u2019aide d\u2019un questionnaire en ligne, compl\u00e9t\u00e9 anonymement et en autonomie. But de l\u2019\u00e9tude : L\u2019objectif est de mieux conna\u00eetre le profil des personnes trans injectrices et leurs pratiques d\u2019injection. R\u00e9sultats : Nous avons pu observer qu\u2019une proportion notable d\u2019injecteur\u00b7rice\u00b7s trans ne b\u00e9n\u00e9ficiait pas d\u2019accompagnement professionnel, aussi bien pour l\u2019obtention du traitement que pour r\u00e9aliser l\u2019injection. Cette situation peut mener \u00e0 certains m\u00e9susages du mat\u00e9riel comme le partage ou la r\u00e9utilisation de celui-ci, qui pr\u00e9sentent des risques non n\u00e9gligeables pour la sant\u00e9. Cela est d\u2019autant plus vrai pour les injecteur\u00b7rice\u00b7s dont le traitement n\u2019est pas accessible l\u00e9galement et qui se fournissent via des march\u00e9s parall\u00e8les. Cette \u00e9tude souligne \u00e9galement l\u2019importance des associations d\u2019auto-support pour accompagner la transition. Conclusions : Nous proposons donc la mise en \u0153uvre d\u2019une politique de r\u00e9duction des risques, adapt\u00e9e aux pratiques des personnes trans, afin de mieux accompagner cette population et d\u2019\u00e9viter l\u2019apparition de probl\u00e8mes de sant\u00e9 importants comme l\u2019infection par le virus de l\u2019immunod\u00e9ficience humaine.<\/jats:p>","DOI":"10.3917\/spub.hs2.0109","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T08:58:13Z","timestamp":1687165093000},"page":"109-122","source":"Crossref","is-referenced-by-count":0,"title":["Hormonoth\u00e9rapie injectable et r\u00e9duction des risques\u00a0: pratiques, difficult\u00e9s, sant\u00e9 des personnes trans en France"],"prefix":"10.3917","volume":"Vol. 34","author":[{"given":"Sara","family":"Jaafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magally","family":"Torres-Leguizamon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Duplessy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Stambolis-Ruhstorfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2273","reference":[{"key":"rb1","unstructured":"1 Giami A, Beaubatie E, Le Bail J. Caract\u00e9ristiques sociod\u00e9mographiques, identifications de genre, parcours de transition m\u00e9dicopsychologiques et VIH\/sida dans la population trans. Premiers r\u00e9sultats d\u2019une enqu\u00eate men\u00e9e en France en 2010. Bull Epidemiol Hebd. 2011;(42):433\u20117."},{"key":"rb2","unstructured":"2 e https:\/\/s.42l.fr\/Hd5bA1xV World Professional Association for Transgender Health (WPATH). Standards de soins pour la sant\u00e9 des personnes transsexuelles, transgenres et de genre non-conforme. 7 \u00e9d. [Internet]. East Dundee, IL (USA)\u00a0: WPATH\u00a0; 2013. 130 p. [Visit\u00e9 le 29\/12\/2022]. En ligne\u00a0: ."},{"key":"rb3","unstructured":"3 https:\/\/www.has-sante.fr\/jcms\/c_894315\/fr\/situation-actuelle-et-perspectives-d-evolution-de-la-prise-en-charge-medicale-du-transsexualisme-en-france Haute Autorit\u00e9 de sant\u00e9 (HAS). Situation actuelle et perspectives d\u2019\u00e9volution de la prise en charge m\u00e9dicale du transsexualisme en France [Internet]. Saint-Denis\u00a0: HAS\u00a0; 2010. [Visit\u00e9 le 29\/12\/2022]. En ligne\u00a0: ."},{"key":"rb4","unstructured":"4 https:\/\/base-donnees-publique.medicaments.gouv.fr\/extrait.php?specid=68178899 Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9. Fiche info \u2013 Androtardyl 250 mg\/1 ml, solution injectable intramusculaire [Internet]. Saint-Denis\u00a0: Base de donn\u00e9es publique des m\u00e9dicaments\u00a0; 2022. [Visit\u00e9 le 29\/12\/2022]. En ligne\u00a0: ."},{"key":"rb5","unstructured":"5 https:\/\/transfemscience.org\/articles\/injectable-e2-meta-analysis\/ Aly. An informal meta-analysis of estradiol curves with injectable estradiol preparations [Internet]. Transfem Sci. 2021 July 16. [Visit\u00e9 le 29\/12\/2022]. En ligne\u00a0: ."},{"key":"rb6","doi-asserted-by":"publisher","first-page":"2995-3001","DOI":"10.1111\/jsm.12691","article-title":"People with Gender Dysphoria Who Self\u2010Prescribe Cross\u2010Sex Hormones: Prevalence, Sources, and Side Effects Knowledge","volume":"11","author":"Mepham Nick","year":"2014","journal-title":"The Journal of Sexual Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/1743-6095","issn-type":"print"},{"key":"rb7","unstructured":"7 Haute Autorit\u00e9 de sant\u00e9 (HAS). Sexe, genre et sant\u00e9. Rapport d\u2019analyse prospective 2020. Saint-Denis\u00a0; HAS\u00a0: 2020. 217 p."},{"key":"rb9","unstructured":"9 https:\/\/transequality.org\/sites\/default\/files\/docs\/usts\/USTS-Full-Report-Dec17.pdf James SE, Herman JL, Rankin S, Keisling M, Mottet L, Anafi M. The report of the 2015 U.S. transgender survey [Internet]. Washington, DC: National Center for Transgender Equality; 2016. 302 p. [Visit\u00e9 le 29\/12\/2022]. En ligne\u00a0: ."},{"key":"rb10","doi-asserted-by":"publisher","first-page":"null","DOI":"10.1017\/S1463423620000638","article-title":"The expectations of transgender people in the face of their health-care access difficulties and how they can be overcome. A qualitative study in France","volume":"21","author":"Allory Emmanuel","year":"2020","journal-title":"Primary Health Care Research & Development","ISSN":"https:\/\/id.crossref.org\/issn\/1463-4236","issn-type":"print"},{"key":"rb11","unstructured":"11 https:\/\/chrysalide-asso.fr\/nos-documents\/enquete-chrysalide-sante-trans-2011\/ Chrysalide. Enqu\u00eate Chrysalide \u00ab\u00a0Sant\u00e9 trans 2011\u00a0\u00bb. Pr\u00e9-rapport [Internet]. Lyon\u00a0: Chrysalide\u00a0; 2011. 34 p. [Visit\u00e9 le 29\/12\/2022]. En ligne\u00a0: ."},{"key":"rb12","unstructured":"12 https:\/\/books.openedition.org\/msha\/4833 Alessandrin A, Espineira K. Sociologie de la transphobie [Internet]. Pessac\u00a0: Maison des sciences de l\u2019homme d\u2019Aquitaine\u00a0; 2015. 182 p. [Visit\u00e9 le 29\/12\/2022]. En ligne\u00a0: ."},{"key":"rb13","doi-asserted-by":"publisher","first-page":"S210-S219","DOI":"10.1097\/QAI.0000000000001087","article-title":"Global Epidemiology of HIV Infection and Related Syndemics Affecting Transgender People","volume":"72","author":"Poteat Tonia","year":"2016","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes","ISSN":"https:\/\/id.crossref.org\/issn\/1525-4135","issn-type":"print"},{"key":"rb14","doi-asserted-by":"publisher","first-page":"1070-1081","DOI":"10.1111\/add.12125","article-title":"Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?","volume":"108","author":"de Vos Anneke S.","year":"2013","journal-title":"Addiction","ISSN":"https:\/\/id.crossref.org\/issn\/0965-2140","issn-type":"print"},{"key":"rb15","doi-asserted-by":"publisher","first-page":"1603-1621","DOI":"10.1080\/10826080600847951","article-title":"Impact of a Harm-Reduction Policy on HIV and Hepatitis C Virus Transmission Among Drug Users: Recent French Data\u2014The ANRS-Coquelicot Study","volume":"41","author":"Jauffret-Roustide M.","year":"2006","journal-title":"Substance Use & Misuse","ISSN":"https:\/\/id.crossref.org\/issn\/1082-6084","issn-type":"print"},{"key":"rb16","doi-asserted-by":"publisher","first-page":"null","DOI":"10.1186\/s12954-020-00403-1","article-title":"HaRePo (harm reduction by post): an innovative and effective harm reduction programme for people who use drugs using email, telephone, and post service","volume":"17","author":"Torres-Leguizamon Magally","year":"2020","journal-title":"Harm Reduction Journal","ISSN":"https:\/\/id.crossref.org\/issn\/1477-7517","issn-type":"print"},{"key":"rb17","unstructured":"17 https:\/\/transpolicyreform.wordpress.com\/2022\/10\/08\/transgender-research-informed-consent-tricon-disclosure-policy-2022-update\/ Winter K, D\u2019Orsay AE, Sirenu V, Con AR. Transgender Research Informed Consent (TRICON) Disclosure Policy [Internet]. 2022 [Visit\u00e9 le 29\/12\/2022]. En ligne\u00a0: ."},{"key":"rb18","unstructured":"18 https:\/\/s.42l.fr\/guxzWQSb https:\/\/www.healthline.com\/health\/drugs\/testosterone-cypionate-injectable-solution University of Illinois, Aremu F. Testosterone cypionate, injectable solution [Internet]. New York (USA): Healthline; 2021. [Visit\u00e9 le 29\/12\/2022]. En ligne\u00a0: . ."},{"key":"rb19","doi-asserted-by":"publisher","first-page":"421-427","DOI":"10.1016\/j.ecl.2019.02.006","article-title":"Osteoporosis and Bone Health in Transgender Persons","volume":"48","author":"Stevenson Mary O.","year":"2019","journal-title":"Endocrinology and Metabolism Clinics of North America","ISSN":"https:\/\/id.crossref.org\/issn\/0889-8529","issn-type":"print"},{"key":"rb20","unstructured":"20 https:\/\/www.conseil-national.medecin.fr\/sites\/default\/files\/fiche_memo_prescription_et_delivrance_hors_amm.pdf Conseil national de l\u2019ordre des m\u00e9decins (Cnom), Conseil national de l\u2019ordre des pharmaciens (Cnop). Fiche pratique. La prescription et d\u00e9livrance de m\u00e9dicaments hors AMM [Internet]. Paris\u00a0: Cnom, Cnop\u00a0; 2020. 2 p. [Visit\u00e9 le 29\/12\/2022]. En ligne\u00a0: ."},{"key":"rb21","unstructured":"21 https:\/\/www.legifrance.gouv.fr\/codes\/article_lc\/LEGIARTI000006913892\/2020-12-28 R\u00e9publique fran\u00e7aise. Article R4311-5 du Code de la sant\u00e9 publique [Internet]. Paris\u00a0; 2004. [Visit\u00e9 le 29\/12\/2022]. En ligne\u00a0: ."},{"key":"rb22","doi-asserted-by":"publisher","first-page":"662-667","DOI":"10.1016\/S1297-9589(01)00207-7","article-title":"Acceptabilit\u00e9 et int\u00e9r\u00eat de l\u2019auto-injection de gonadotrophines pour la stimulation en vue d\u2019une ins\u00e9mination intra-ut\u00e9rine","volume":"29","author":"Zorn J.R","year":"2001","journal-title":"Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9","ISSN":"https:\/\/id.crossref.org\/issn\/1297-9589","issn-type":"print"},{"key":"rb23","doi-asserted-by":"publisher","first-page":"303-313","DOI":"10.1016\/j.contraception.2016.06.006","article-title":"Interest in self-administration of subcutaneous depot medroxyprogesterone acetate in the United States","volume":"94","author":"Upadhyay Ushma D.","year":"2016","journal-title":"Contraception","ISSN":"https:\/\/id.crossref.org\/issn\/0010-7824","issn-type":"print"},{"key":"rb24","doi-asserted-by":"publisher","first-page":"99-101","DOI":"10.1097\/00000446-196304000-00021","article-title":"Intramuscular Injection Injuries And Complications","volume":"63","author":"Hanson Daniel J.","year":"1963","journal-title":"AJN, American Journal of Nursing","ISSN":"https:\/\/id.crossref.org\/issn\/0002-936X","issn-type":"print"},{"key":"rb25","unstructured":"25 https:\/\/www.plannedparenthood.org\/uploads\/filer_public\/d7\/ab\/d7ab6e07-cce2-4ae9-87e0-be49547c3b56\/ppgt3717_how_to_give_yourself_a_hormone_injection_-_intramuscular_im.pdf Planned parenthood of Greater Texas. How to give yourself a hormone injection \u2013 Intramuscular (IM) [Internet]. Dallas, TX (USA): Planned parenthood of Greater Texas; 2018. 3 p. [Visit\u00e9 le 29\/12\/2022]. En ligne\u00a0: ."},{"key":"rb26","unstructured":"26 https:\/\/apps.who.int\/iris\/handle\/10665\/255548 Organisation mondiale de la sant\u00e9 (OMS). Lignes directrices de l\u2019OMS sur l\u2019utilisation de seringues s\u00e9curis\u00e9es pour les injections intramusculaires, intradermiques et sous-cutan\u00e9es dans les structures de soins [Internet]. Gen\u00e8ve\u00a0: OMS\u00a0; 2016. 53 p. [Visit\u00e9 le 29\/12\/2022]. En ligne\u00a0: ."},{"key":"rb27","doi-asserted-by":"publisher","first-page":"274-278","DOI":"10.1016\/j.drugalcdep.2014.08.018","article-title":"Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia","volume":"144","author":"Wilson Hannah","year":"2014","journal-title":"Drug and Alcohol Dependence","ISSN":"https:\/\/id.crossref.org\/issn\/0376-8716","issn-type":"print"},{"key":"rb28","doi-asserted-by":"publisher","first-page":"47-66","DOI":"10.3917\/gen.102.0047","article-title":"De la fabrique des militant-e-s \u00e0 la fabrique des patient-e-s","volume":"n\u00b0 102","author":"Gelly Maud","year":"2016","journal-title":"Gen\u00e8ses","ISSN":"https:\/\/id.crossref.org\/issn\/1155-3219","issn-type":"print"},{"key":"rb29","unstructured":"29 Beaubatie E. Transfuges de sexe\u00a0: passer les fronti\u00e8res du genre. Paris\u00a0: La D\u00e9couverte\u00a0; 2021. 192 p."},{"key":"rb30","unstructured":"30 Bouscarat F. Complications dermatologiques observ\u00e9es chez les personnes transgenres. Images Dermatol. 2015;3(6):218\u201124."}],"container-title":["Sant\u00e9 Publique"],"original-title":[],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T03:44:33Z","timestamp":1695354273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cairn.info\/revue-sante-publique-2022-HS2-page-109.htm?ref=doi"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2023,5,7]]},"references-count":29,"journal-issue":{"issue":"HS2","published-print":{"date-parts":[[2023,5,7]]}},"URL":"https:\/\/doi.org\/10.3917\/spub.hs2.0109","relation":{},"ISSN":["0995-3914"],"issn-type":[{"type":"print","value":"0995-3914"}],"subject":[],"published":{"date-parts":[[2023,5,7]]}}}